Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.

Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.

Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.

In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.